Selim Kuci

Summary

Affiliation: Johann Wolfgang Goethe University
Country: Germany

Publications

  1. ncbi Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases
    Caroline M Wernicke
    Children s Cancer Research and Roman Herzog Comprehensive Cancer Center, Department of Pediatrics, Klinikum rechts der Isar, Technische Universitat Munchen, Kolner Platz 1, 80804 Munich, Germany
    Int Arch Med 4:27. 2011
  2. ncbi Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine
    Selim Kuci
    University Children s Hospital III, Department of Hematology Oncology, Frankfurt am Main, Germany
    Curr Stem Cell Res Ther 4:107-17. 2009
  3. ncbi Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells
    S Kuci
    University Children s Hospital, Department of Hematology Oncology, University of Tubingen, Tubingen, Germany
    Cell Prolif 41:12-27. 2008
  4. ncbi Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation
    Selim Kuci
    University Children s Hospital III, University Children s Hospital III, Department of Hematology Oncology Department of Hematology Oncology, Theodor Stern Kai 7
    Haematologica 95:1579-86. 2010
  5. ncbi CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties
    Selim Kuci
    Department of Hematology Oncology, University Children s Hospital III, 60590 Frankfurt am Main, Germany
    Haematologica 95:651-9. 2010
  6. ncbi CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin
    Hans Jorg Buhring
    University of Tubingen, Department of Internal Medicine II, Division of Hematology, Immunology, Oncology and Rheumatology, Tubingen, Germany
    Stem Cells 22:334-43. 2004
  7. ncbi Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties
    Zyrafete Kuçi
    University Children s Hospital, Department of Hematology Oncology, Frankfurt am Main, Germany
    Cytotherapy 13:1193-204. 2011
  8. ncbi CDCP1 is a novel marker for hematopoietic stem cells
    Tim Conze
    Department of Internal Medicine II, Division of Hematology, Immunology, and Oncology, University of Tubingen, Tubingen, Germany
    Ann N Y Acad Sci 996:222-6. 2003
  9. ncbi Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells
    Selim Kuci
    Department of Hematology Oncology, University Children s Hospital, Tubingen, Germany
    Blood 101:869-76. 2003
  10. ncbi The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells
    Takafumi Kimura
    Department of Medicine II, University of Tubingen, Otfried Muller Strasse 10, 72076 Tubingen, Germany
    Blood 103:4478-86. 2004

Collaborators

Detail Information

Publications12

  1. ncbi Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases
    Caroline M Wernicke
    Children s Cancer Research and Roman Herzog Comprehensive Cancer Center, Department of Pediatrics, Klinikum rechts der Isar, Technische Universitat Munchen, Kolner Platz 1, 80804 Munich, Germany
    Int Arch Med 4:27. 2011
    ....
  2. ncbi Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine
    Selim Kuci
    University Children s Hospital III, Department of Hematology Oncology, Frankfurt am Main, Germany
    Curr Stem Cell Res Ther 4:107-17. 2009
    ..Herein we discuss the differentiation and reprogramming potential of both hematopoietic and non- hematopoietic stem cells along endodermal, mesodermal and neuroectodermal lineage and their importance for regenerative medicine...
  3. ncbi Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells
    S Kuci
    University Children s Hospital, Department of Hematology Oncology, University of Tubingen, Tubingen, Germany
    Cell Prolif 41:12-27. 2008
    ..To generate non-haematopoietic tissues from mobilized haematopoietic CD133(+) stem cells...
  4. ncbi Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation
    Selim Kuci
    University Children s Hospital III, University Children s Hospital III, Department of Hematology Oncology Department of Hematology Oncology, Theodor Stern Kai 7
    Haematologica 95:1579-86. 2010
    ..Here we assessed the capability of ex vivo expanded cytokine-induced killer cells to lyse both alveolar and embryonic rhabdomyosarcoma cell lines and investigated the mechanisms involved...
  5. ncbi CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties
    Selim Kuci
    Department of Hematology Oncology, University Children s Hospital III, 60590 Frankfurt am Main, Germany
    Haematologica 95:651-9. 2010
    ..The co-transplantation of such cells together with hematopoietic stem cells in patients with hematologic malignancies may prove valuable in the prevention of impaired/delayed T-cell recovery and graft-versus-host disease...
  6. ncbi CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin
    Hans Jorg Buhring
    University of Tubingen, Department of Internal Medicine II, Division of Hematology, Immunology, Oncology and Rheumatology, Tubingen, Germany
    Stem Cells 22:334-43. 2004
    ..In conclusion, CDCP1 is not only a novel marker for immature hematopoietic progenitor cell subsets but also unique in its property to recognize cells with phenotypes reminiscent of MSC and NPC...
  7. ncbi Mesenchymal stromal cells derived from CD271(+) bone marrow mononuclear cells exert potent allosuppressive properties
    Zyrafete Kuçi
    University Children s Hospital, Department of Hematology Oncology, Frankfurt am Main, Germany
    Cytotherapy 13:1193-204. 2011
    ..CONCLUSIONS. Our data suggest that CD271-MSC exert potent allosuppressive properties and therefore can be used as a reasonable alternative to PA-MSC for the treatment of patients with graft-versus-host disease...
  8. ncbi CDCP1 is a novel marker for hematopoietic stem cells
    Tim Conze
    Department of Internal Medicine II, Division of Hematology, Immunology, and Oncology, University of Tubingen, Tubingen, Germany
    Ann N Y Acad Sci 996:222-6. 2003
    ..Transplantation of purified CDCP1(+) cells into NOD/SCID mice resulted in engraftment of human cells with multi-lineage differentiation potential, suggesting that CDCP1 is a novel marker for hematopoietic stem cells...
  9. ncbi Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells
    Selim Kuci
    Department of Hematology Oncology, University Children s Hospital, Tubingen, Germany
    Blood 101:869-76. 2003
    ..Hence, these cells possess a distinct in vivo differentiation potential compared with that of CD34(+) stem cells and may therefore provide an alternative to CD34(+) progenitor cells for transplantation...
  10. ncbi The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells
    Takafumi Kimura
    Department of Medicine II, University of Tubingen, Otfried Muller Strasse 10, 72076 Tubingen, Germany
    Blood 103:4478-86. 2004
    ..In the hematopoietic microenvironment, S1PRs are involved in migration and maintenance of HPCs by modulating the effects of SDF-1...
  11. ncbi A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells
    Stephan Kloss
    Paediatric Haematology and Oncology of Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60596 Frankfurt am Main, Germany
    J Immunol Methods 325:140-7. 2007
    ....
  12. ncbi CD133-Positive Hematopoietic Stem Cells: From Biology to Medicine
    Rupert Handgretinger
    University Children s Hospital, Department of Hematology Oncology, Hoppe Seyler Strasse 1, 72076, Tubingen, Germany
    Adv Exp Med Biol 777:99-111. 2013
    ..The availability of methods for clinical large-scale isolation of CD133(+) cells facilitates their use in autologous and allogeneic hematopoietic stem cell transplantation and possibly in other fields of regenerative medicine...